1-2 of 2
Jonas Helma-Smets
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML

Maike Roas, Binje Vick, Marc-André Kasper, Marina Able, Harald Polzer, Marcus Gerlach, Elisabeth Kremmer, Judith S. Hecker, Saskia Schmitt, Andreas Stengl, Verena Waller, Natascha Hohmann, Moreno Festini, Alexander Ludwig, Lisa Rohrbacher, Tobias Herold, Marion Subklewe, Katharina S. Götze, Christian P. R. Hackenberger, Dominik Schumacher, Jonas Helma-Smets, Irmela Jeremias, Heinrich Leonhardt, Karsten Spiekermann
Journal: Blood
Blood (2023) 141 (9): 1023–1035.
https://doi.org/10.1182/blood.2021015246
Published: 2023
Includes: Supplemental data
Journal Articles

Tub-010, a Novel Antibody-Drug-Conjugate with Reduced Nonspecific Toxicity Profile Based on Tub-Tag Technology Widens the Therapeutic Window for the Treatment of CD30+ Malignancies

Marcus Gerlach, Saskia Schmitt, Philipp Cyprys, Marc-André Kasper, Isabelle Mai, Maarten H. Vermeer, Steven M. Horwitz, Guenter R Fingerle-Rowson, Annette Vogl, Dominik Schumacher, Jonas Helma-Smets
Journal: Blood
Blood (2022) 140 (Supplement 1): 9397–9398.
https://doi.org/10.1182/blood-2022-158681
Published: 2022